-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Zai Lab (ZLAB)
-
-
-
-
-
-
-
Scotiabank Starts Edgewise Therapeutics (EWTX) at Sector Outperform
-
-
-
-
-
-
-
Scotiabank Starts Blueprint Medicines (BPMC) at Sector Outperform
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
-
-
-
-
-
-
-
Eli Lilly (LLY) raises FY forecast as diabetes drug Mounjaro excels
-
-
-
-
-
-
-
Cantor Fitzgerald Reinstates TherapeuticsMD (TXMD) at Neutral
-
810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

